SPPH NEWS!!!!! BUY OUT OFFER!!!
BOSTON, MA) Spencer Pharmaceutical Inc. (SPPH) announced today that an unsolicited offer received on November 4, 2010 is at a premium of $0.97 per share, making the potential transaction valued at $245 million.
According to the buyout offer documents, the purchaser is requiring any and all shares be tendered for a purchase price of $0.97 per share and with the intent to privatize the company. Spencer Pharmaceutical (SPPH) has opted to continue to keep the purchaser's name confidential until such time as a timeline can be presented and the approval of the board of directors can be obtained.
Rule No.1: Never lose money. Rule No.2: Never forget rule
No.1. ~Warren Buffett